Dr Anthony De Luca, Senior Scientist
Dr Anthony DeLuca has broad Academic, Research, Industry and 'Government Regulatory' experience, spanning over twenty years. Recently, after completing two post-doctoral positions, he gained experience in the private sector and has also been an external evaluator for the Therapeutic Goods Administration (TGA).
Dr DeLuca has worked in the private sector for the last eight years in accredited Toxicology Laboratories. In this time, he has undertaken Biomedical Safety Testing for biomaterials, devices and medicines using numerous in vivo, in vitro and biochemical assays. He has also provided expert Testing and Regulatory Affairs Consultancy Services to the Pharmaceutical Industry - from providing technical and regulatory advice on issues of regulatory compliance with biomedical safety testing for biomaterials, devices and pharmaceuticals, to providing regulatory advice with product development testing in general.
Dr John Odontiadis, Senior Scientist
Dr. John Odontiadis has over 20 years experience as an analytical chemist with exceptional expertise in chromatographic methods of analysis of compounds from biological fluids which includes LC/MS/MS HPLC and GC. Dr Odontiadis completed his Doctorate degree (Ph.D) and Masters of Philosophy of Science (M. Phil) at Oxford University, UK. Dr Odontiadis also trained in pharmacological methods of investigations encompassing both clinical and pre-clinical studies. Dr Odontiadis's industry experience as Senior Analytical Chemist with CMAX Analytical has also earned him a sound reputation with analytical method developing of drug assays from biological fluids and non-biological matrices utilising HPLC and LC/MS/MS technologies determining the pharmacokinetic profiles of compounds in both clinical and preclinical investigations for pharmaceutical and biotechnology clients in a NATA accredited GLP and FDA compliant environment. Dr Odontiadis collaborations with the international community have earned him a reputation as a sound biological and analytical scientist.
Ms Ling Ling Shen, Senior Scientist
Ms Ling Ling Shen has engaged in the field of safety toxicology and safety pharmacology for 15 years. She achieved sound knowledge through 8 year's undergraduate and postgraduate studies in medical sciences. Her Masters Degree study and the followed further researches resulted in the registration of a Chinese complimentary medicine in China. Ling Ling Shen has experiences on a wide range of regulatory toxicity testing, especially in genetic toxicity testing. She has firm understanding on drug safety regulations and is familiar with various drug registration requirements. She has been working in the GLP environment in this organization since its very beginning.
Mr James Vergis, Senior Scientist
Mr James Vergis has a background in clinical Histology as a Medical Scientist. He has worked in three of the most specialised public health institutions in Melbourne over a 14 year period, mastering all of the routine and specialised aspects inherent in the field of Histology. Concurrently, Mr Vergis has worked in the private Pathology field for the past 10 years, thus gaining extended insight into Laboratory operations with an emphasis on commercial imperatives. Mr Vergis received his B.Sc. (Hon) from the University of Melbourne, as well as Project Management training from Swinburne University. Mr Vergis has been responsible for the organisation, improvement and functioning of the Histology laboratory within RDDT since joining the company early in 2007.